Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
BMC Gastroenterology|January 19, 2011
Complete response for advanced liver cancer during sorafenib therapy: case reportRodolfo Sacco, Irene Bargellini, Giannelli Gianluigi, et al.
Cancers|December 19, 2020
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsAntonio Facciorusso, Mohamed A Abd El Aziz, Nicola Tartaglia, et al.
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
Intervirology|September 11, 2010
Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis CGiovanna A Moscato, Gianluigi Giannelli, Barbara Grandi, et al.
Journal of Crohn'S & Colitis|July 23, 2013
Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational studyRodolfo Sacco, Antonio Romano, Alessandro Mazzoni, et al.
Digestive Diseases and Sciences|November 17, 2014
Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experienceMauro Borzio, Elena Dionigi, Angelo Rossini, et al.
World Journal of Hepatology|January 28, 2015
Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsRodolfo Sacco, Valeria Mismas, Antonio Romano, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Bridging Gaps in Cancer Pain Care: Barriers, Solutions, and a Path Forward for Integrated ManagementMarta Gentili, Francesco Cellini, Leonardo Consoletti, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Biomedicines|November 27, 2021
Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular CarcinomaDaryl Ramai, Khoi P Dang-Ho, Anjali Kewalramani, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
BMC Gastroenterology|January 19, 2011
Complete response for advanced liver cancer during sorafenib therapy: case reportRodolfo Sacco, Irene Bargellini, Giannelli Gianluigi, et al.
Cancers|December 19, 2020
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsAntonio Facciorusso, Mohamed A Abd El Aziz, Nicola Tartaglia, et al.
Cancers|December 24, 2021
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple ConfoundersLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
Intervirology|September 11, 2010
Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis CGiovanna A Moscato, Gianluigi Giannelli, Barbara Grandi, et al.
Journal of Crohn'S & Colitis|July 23, 2013
Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational studyRodolfo Sacco, Antonio Romano, Alessandro Mazzoni, et al.
Digestive Diseases and Sciences|November 17, 2014
Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experienceMauro Borzio, Elena Dionigi, Angelo Rossini, et al.
World Journal of Hepatology|January 28, 2015
Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsRodolfo Sacco, Valeria Mismas, Antonio Romano, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Bridging Gaps in Cancer Pain Care: Barriers, Solutions, and a Path Forward for Integrated ManagementMarta Gentili, Francesco Cellini, Leonardo Consoletti, et al.
Current Oncology (Toronto, Ont.)|January 26, 2024
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic TherapyLuca Ielasi, Bernardo Stefanini, Fabio Conti, et al.
Biomedicines|November 27, 2021
Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular CarcinomaDaryl Ramai, Khoi P Dang-Ho, Anjali Kewalramani, et al.
Pageof 17